Skip to main content
. 2018 Oct 8;10(10):e3421. doi: 10.7759/cureus.3421

Table 2. Relationship between thyroid hormone profile and platelet count and mean platelet volume.

TSH: thyroid stimulating hormone; T4: L-thyroxine; T3: 3, 3′, 5-L-triiodothyronine; CI: confidence interval; REF: reference quartile

  Platelet Count (103 platelets/uL) Mean Platelet Volume (attoliters)
  Unadjusted Adjusted Unadjusted Adjusted
  Mean difference (95% CI) P-value Mean difference (95% CI) P-value Mean difference (95% CI) P-value Mean difference (95% CI) P-value
TSH (uIU/mL)                
TSH -3.35 (-5.45 to -1.26) 0.002 -2.09 (-4.29 to 0.11) 0.06 -3.48 (-35.69 to 28.72) 0.83 12.28 (-21.8 to 46.36) 0.47
TSH Q1 REF   REF   REF   REF  
TSH Q2 -6.31 (-12 to -0.62) 0.03 -4.97 (-11.05 to 1.11) 0.11 55.01 (-24.68 to 134.7) 0.17 92.21 (-1.2 to 185.62) 0.05
TSH Q3 -6.27 (-11.35 to -1.19) 0.02 -6.66 (-12.37 to -0.94) 0.02 99.53 (30.36 to 168.69) 0.005 103.72 (24.62 to 182.82) 0.01
TSH Q4 -8.09 (-13.6 to -2.59) 0.004 -5.83 (-10.92 to -0.73) 0.03 -5 (-84.23 to 74.24) 0.90 49.73 (-30.38 to 129.85) 0.22
Serum T4 (ug/mL)                
T4 4.09 (2.9 to 5.27) <0.001 2.03 (0.7 to 3.36) 0.003 28.12 (9.67 to 46.56) 0.003 30.92 (6.44 to 55.39) 0.01
T4 Q1 REF   REF   REF   REF  
T4 Q2 4.6 (0.11 to 9.08) 0.04 2.07 (-2.53 to 6.67) 0.37 39.38 (-32.76 to 111.52) 0.28 34.31 (-57.51 to 126.14) 0.46
T4 Q3 9.88 (5 to 14.76) <0.001 4.07 (-1.06 to 9.21) 0.12 47.76 (-34.24 to 129.75) 0.25 74.23 (-25.29 to 173.75) 0.14
T4 Q4 15.65 (10.5 to 20.79) <0.001 7.83 (1.84 to 13.82) 0.01 102.38 (28.49 to 176.28) 0.007 109.64 (1.1 to 218.18) 0.05
Serum Free T4 (ng/dL)                
Free T4 -27.84 (-47.27 to -8.42) 0.006 -18.87 (-39.39 to 1.65) 0.07 544.08 (191.9 to 896.26) 0.003 534.48 (151.85 to 917.11) 0.007
Free T4 Q1 REF   REF   REF   REF  
Free T4 Q2 -5.79 (-10.64 to -0.94) 0.02 -4.53 (-9.97 to 0.92) 0.10 107.78 (22.24 to 193.32) 0.01 89.94 (-12.01 to 191.9) 0.08
Free T4 Q3 -17.5 (-24.58 to -10.42) <0.001 -15.64 (-24.06 to -7.23) <0.001 282.47 (144.1 to 420.84) <0.001 236.22 (90.14 to 382.3) 0.002
Free T4 Q4 -7.17 (-12.85 to -1.49) 0.01 -4.95 (-11.13 to 1.24) 0.11 123.59 (29.05 to 218.12) 0.01 124.42 (24.06 to 224.78) 0.02
Serum T3 (ng/dL)                
T3 0.09 (-0.02 to 0.19) 0.09 -0.05 (-0.17 to 0.07) 0.38 2.85 (1.16 to 4.54) 0.001 2.66 (0.65 to 4.66) 0.01
T3 Q1 REF   REF   REF   REF  
T3 Q2 4.35 (-1.55 to 10.25) 0.14 -0.53 (-6.72 to 5.67) 0.86 125.58 (40.97 to 210.19) 0.004 123.63 (16.77 to 230.49) 0.02
T3 Q3 5.03 (-1.52 to 11.58) 0.13 0.46 (-6.7 to 7.62) 0.90 58.5 (-46.67 to 163.67) 0.27 68.68 (-40.84 to 178.19) 0.21
T3 Q4 4.33 (-2.74 to 11.39) 0.22 -3.16 (-10.89 to 4.56) 0.41 176.63 (71.4 to 281.86) 0.001 160.25 (36.39 to 284.11) 0.01
Serum Free T3 (pg/mL)                
Free T3 6.84 (0.8 to 12.88) 0.03 4.32 (-3.71 to 12.36) 0.28 61.5 (-55.48 to 178.48) 0.30 6.03 (-105.51 to 117.56) 0.91
Free T3 Q1 REF   REF   REF   REF  
Free T3 Q2 -0.16 (-6.76 to 6.44) 0.96 -1.35 (-9.03 to 6.33) 0.73 121.5 (37.24 to 205.75) 0.006 116.67 (-0.22 to 233.56) 0.05
Free T3 Q3 2.31 (-4.48 to 9.09) 0.50 1.88 (-5.98 to 9.73) 0.63 290.15 (139.43 to 440.87) <0.001 118.17 (12.21 to 224.13) 0.03
Free T3 Q4 4.04 (-1.96 to 10.03) 0.18 0.79 (-7.07 to 8.66) 0.84 131.44 (39.53 to 223.35) 0.006 56 (-60.14 to 172.14) 0.34